Welcome to the ESID 2021 Online Meeting Interactive Programme

The meeting will officially run on Central European Summer Time (CEST)
To convert the meeting times to your local time Click Here

Icons Legend:  - Live Session   - Pre-recorded with Live Q&A

Browsing Over 139 Presentations

Sort By Relevance

RITUXIMAB USE, MONITORING AND OUTCOMES IN A LARGE TERTIARY INTEGRATED CHILDREN'S HOSPITAL, 2015-2020

Presenter
  • Christo Tsilifis (United Kingdom)
Lecture Time
11:17 - 11:25

ANTENATAL EXPOSURE TO ANTI-TNF-ALPHA: EFFECT ON THE NEWBORNS’ IMMUNE SYSTEM

Presenter
  • Yiyi Luo (Spain)
Lecture Time
11:17 - 11:25

A CASE SERIES OF PATIENTS WITH HYPOGAMMAGLOBULINEMIA AND SYSTEMIC SCLEROSIS: A CORRELATION THAT MUST NOT BE OVERLOOKED

Presenter
  • Maria Giovanna Danieli (Italy)
Lecture Time
11:49 - 11:57

RITUXIMAB THERAPY IN NEUROLOGY-A SINGLE CENTER EXPERIENCE

Presenter
  • Rajeswari Aghoram (India)
Lecture Time
11:25 - 11:33

IN VITRO EFFECT OF JAK INHIBITION ON THE IFN-MEDIATED HYPERRESPONSE OF PATIENTS WITH STAT3 LOF MUTATIONS

Presenter
  • Pilar Blanco Lobo (Spain)
Lecture Time
11:25 - 11:33

OUTCOMES FOLLOWING SARS-COV-2 INFECTION IN PATIENTS WITH SYMPTOMATIC SECONDARY IMMUNODEFICIENCY: THE UK EXPERIENCE

Presenter
  • Adrian Shields (United Kingdom)
Lecture Time
11:25 - 11:33

BIOMARKERS DIFFERENTIATING INDIVIDUALS REQUIRING PROPHYLACTIC ANTIBIOTICS FROM THOSE REQUIRING IMMUNOGLOBULIN REPLACEMENT AS TREATMENT FOR SECONDARY IMMUNODEFICIENCY FOLLOWING HAEMATOLOGICAL MALIGNANCY

Presenter
  • Adrian Shields (United Kingdom)
Lecture Time
11:57 - 12:05

IMMUNOGLOBULIN MONITORING IN A PEDIATRIC AUTOIMMUNE DISEASE COHORT TREATED WITH RITUXIMAB

Presenter
  • Yousuf Karim (Qatar)
Lecture Time
11:25 - 11:33

IMMUNOLOGICAL RESPONSES TO SARS-COV-2 NATURAL INFECTION AND VACCINATION IN INDIVIDUALS WITH ANTIBODY DEFICIENCY: THE COV-AD STUDY

Presenter
  • Adrian Shields (United Kingdom)
Lecture Time
14:41 - 14:49

Genetic and Immunological Causes of Life-Threatening COVID-19

Presenter
  • Jean-Laurent Casanova (United States of America)
Lecture Time
17:37 - 18:07

Risk Serious and Opportunistic Infections with Biologic and Small Molecular Therapies

Presenter
  • Kevin Winthrop (United States of America)
Lecture Time
18:07 - 18:37

Live Q&A

Lecture Time
18:37 - 18:52